Therefore, these new discoveries led to the investigation of promising therapies, such as immunotherapies against specific antigens (for example, against thyroid-stimulating-hormone receptor), to restore immune tolerance against the dominant immune epitopes associated with the autoimmunity in Graves’ disease. This evidence concerns the gene TSHR and Graves disease.